38
Participants
Start Date
May 31, 2011
Primary Completion Date
October 31, 2011
Study Completion Date
December 31, 2011
Tapentadol
Subjects received tapentadol immediate release formulation, 75 mg three times per day (tid) for 48 hours.
Oxycodone
Subjects received oxycodone immediate release formulation, 5 mg three times per day (tid) for 48 hours.
Placebo
Subjects received placebo three times per day (tid) for 48 hours.
Mayo Clinic in Rochester, Rochester
Lead Sponsor
National Center for Research Resources (NCRR)
NIH
Mayo Clinic
OTHER